Jakafi 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FQLL4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,793
Award facts
- Contract value 100% obligated
- $24,793.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,793.16 to DMS Pharmaceutical Group Inc. for JAKAFI 5 mg tablets (60-count units) on November 20, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform work at its Park Ridge facility. This delivery order was issued under a firm fixed-price contract structure with no set-aside designation, allowing the vendor to compete on an unrestricted basis. The ultimate completion date is November 21, 2025.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to support recurring pharmaceutical and medical supply needs of Department of Defense healthcare facilities worldwide. The parent IDC, designated SPE2DR and valued at $499.999 billion, was awarded on November 13, 2025, with a completion date of December 31, 2036, and includes a 30-month base period with three 30-month option periods. DMS Pharmaceutical Group's established performance across the pharmaceutical supply chain positions it as a critical supplier of branded and generic prescription medications, biologics, and medical consumables for military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FQLL4?
SPE2DR26FQLL4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FQLL4 worth?
The government has obligated $24,793 on SPE2DR26FQLL4.
Is contract SPE2DR26FQLL4 an order under another contract?
Yes. SPE2DR26FQLL4 is a delivery order under SPE2DR25D9354, an indefinite delivery contract.
Was contract SPE2DR26FQLL4 competed?
The extent of competition for SPE2DR26FQLL4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award